Table 2B.

Patient Characteristic and Association with Elevated yδ T cells after HSCT (Logistic Model)

Variable	Category	Estimate	Pr>Chi-Square	Odds Ratio (95% CI)
Donor			0.256	.
	CORD		.	.
	HAPLO	3.169	0.981	23 E3 (0.00, I)
	MRD	3.891	0.976	475E3 (0.00, I)
	MURD	2.119	0.987	80776 (0.00, I)
Age		−0.048	0.381	0.953 (0.856, 1.061)
Gender	Male vs Female	−0.052	0.870	0.900 (0.256, 3.164)
Diagnosis	AML vs ALL	−0.113	0.732	0.797 (0.218, 2.916)
GVHD Prophylaxis	CSA & MMF	−0.019	0.973	0.963 (0.109, 8.519)
	MTX & FK	−0.050	0.880	0.904 (0.246, 3.327)
	ATG ± OKT3	0.059	0.887	1.126 (0.221, 5.742)
Acute GVHD	Yes vs. No	0.4878	0.144	1.629 (0.847, 3.131)
Chronic GVHD	Yes vs. No	−5.668	0.958	0.000 (0.00, 1E177)
Relapse	Yes vs. No	−0.485	0.369	0.379 (0.046, 3.147)
Survival	Yes vs. No	−0.916	0.087	0.160 (0.020, 1.305)
Infection	Yes vs. No	−0.829	0.041*	0.190 (0.039, 0.931)
Infection Groups			0.718	.
	Bacterial			.
	Fungal	−4.641	0.983	1.000 (0.000, 2E246)
	None	5.114	0.944	17235 (0.000, 33E52)
	Viral	4.169	0.954	6703 (0.000, 13E52)
Immune	CD3	0.729	0.003*	2.073 (1.288, 3.335)
Recovery	CD4	2.067	0.003*	7.897 (2.007, 31.08)
	CD 8	0.562	0.033*	1.755 (1.048, 2 .939)
	CD19	0.256	0.474	1.292 (0.641, 2.604)
	NK	0.988	0.134	2.684 (0.736, 9.785)